|
ARL6IP4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.321700E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.877300E-03 |
| Normal-vs-Stage2 |
3.344400E-01 |
| Normal-vs-Stage3 |
1.494390E-01 |
| Normal-vs-Stage4 |
4.124000E-01 |
| Stage1-vs-Stage2 |
1.514070E-02 |
| Stage1-vs-Stage3 |
9.089800E-01 |
| Stage1-vs-Stage4 |
9.053600E-01 |
| Stage2-vs-Stage3 |
8.502400E-02 |
| Stage2-vs-Stage4 |
1.752970E-01 |
| Stage3-vs-Stage4 |
9.636800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.666390E-02 |
| Normal-vs-AfricanAmerican |
4.545500E-02 |
| Normal-vs-Asian |
9.794200E-01 |
| Caucasian-vs-AfricanAmerican |
3.983600E-01 |
| Caucasian-vs-Asian |
6.147000E-01 |
| AfricanAmerican-vs-Asian |
5.239000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.141700E-03 |
| Normal-vs-Female |
2.980200E-01 |
| Male-vs-Female |
4.385400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.383970E-01 |
| Normal-vs-Extreme_Weight |
3.142300E-03 |
| Normal-vs-Obese |
1.051190E-01 |
| Normal-vs-Extreme_Obese |
4.323400E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.225800E-01 |
| Normal_Weight-vs-Obese |
7.389800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.746100E-02 |
| Extreme_Weight-vs-Obese |
3.831200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.220300E-02 |
| Obese-vs-Extreme_Obese |
2.229800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.972200E-02 |
| Normal-vs-Age(41-60Yrs) |
7.873900E-02 |
| Normal-vs-Age(61-80Yrs) |
2.622400E-02 |
| Normal-vs-Age(81-100Yrs) |
6.933000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.212600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.294600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.470400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.922800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.587800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.194800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.25249999999244E-05 |
| Normal-VS-Type2 PRCC |
9.292600E-01 |
| Normal-VS-KIRP CIMP |
1.643790E-01 |
| Normal-VS-Unclassified PRCC |
2.652600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.542500E-03 |
| Type1 PRCC-VS-KIRP CIMP |
4.244400E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.315210E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.733200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.450400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.038820E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.596620E-01 |
| Normal-vs-N1 |
4.187200E-01 |
| Normal-vs-N2 |
6.805800E-02 |
| N0-vs-N1 |
7.754200E-01 |
| N0-vs-N2 |
1.510220E-01 |
| N1-vs-N2 |
7.976400E-02 |
|
|
